Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration
- Monday, March 1, 2021, 7:16
- PR Newswire
- Add a comment
DUBLIN, March 1, 2021 /PRNewswire/ — Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, announced today that it has reached a definitive agreement to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners, LLC for total…
About the Author
admin has written 20720 stories on this site.